氧马通过增加TOR1AIP1表达来抑制细胞癌的进展
Xuechuan Yan1, Kai Zhao2, Zongliang Zhang2
1Department of Urology, the Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Frontiers in pharmacology
|October 20, 2025
概括
氧氨酸 (OMT) 通过对TOR1AIP1进行上调来抑制细胞癌 (RCC),该TOR1AIP1禁用了JNK通路. 这项研究揭示了OMT.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 氧氨酸 (OMT) 来自Radix sophorae tonkinensis,表现出抗癌性质.
- 细胞癌 (RCC) 是一个重要的全球健康问题,需要新的治疗策略.
研究的目的:
- 研究OMT对RCC的抗癌作用.
- 阐明OMT在RCC中的作用背后的分子机制.
- 在RCC中识别OMT的潜在分子标.
主要方法:
- RNA测序 (RNA-seq) 用于识别OMT调节的基因.
- 使用RCC细胞系 (Caki-1,786-O) 进行体外研究,以评估OMT对增殖,迁移和入侵的影响.
- 过度表达研究证实了目标基因TOR1AIP1.1的作用.
- 使用裸体小鼠模型进行体内研究,以评估OMT对瘤生长的影响.
主要成果:
- TOR1AIP1被确定为一个由OMT调节的关键目标基因.
- 在RCC细胞中,OMT显著增加了TOR1AIP1的表达.
- 通过对TOR1AIP1.1.进行上调,OMT抑制了RCC细胞的增殖,迁移和入侵.
- 对TOR1AIP1的升级抑制了JNK信号通路,抑制了RCC的发展.
- 在体内,OMT治疗显著抑制了瘤生长.
结论:
- OMT通过TOR1AIP1的上调和随后的JNK信号通路的失活来抑制RCC的进展.
- 在RCC中,TOR1AIP1充当OMT抗瘤作用的机制调解者.
- 对OMT作为潜在的RCC治疗方法进行进一步的体内评估和药理动力学/毒性研究是有必要的.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.2K
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
14.1K
相关概念视频
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:20The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K